These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22301805)

  • 1. Assessment of DNA nucleo base oxidation and antioxidant defense in postmenopausal women under hormone replacement therapy.
    Akcay T; Dincer Y; Saygili EI; Seyisoğlu H; Ertunğalp E
    Indian J Med Sci; 2010 Jan; 64(1):17-25. PubMed ID: 22301805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of DNA damage in postmenopausal women under hormone replacement therapy.
    Ozcagli E; Sardas S; Biri A
    Maturitas; 2005 Jul; 51(3):280-5. PubMed ID: 15978971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HRT decreases DNA and lipid oxidation in postmenopausal women.
    Escalante Gómez C; Quesada Mora S
    Climacteric; 2013 Feb; 16(1):104-10. PubMed ID: 22530644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen plus progestin increase superoxide dismutase and total antioxidant capacity in postmenopausal women.
    Unfer TC; Figueiredo CG; Zanchi MM; Maurer LH; Kemerich DM; Duarte MM; Konopka CK; Emanuelli T
    Climacteric; 2015 Jun; 18(3):379-88. PubMed ID: 25236970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
    Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
    Menopause; 2018 Nov; 25(11):1214-1223. PubMed ID: 30358716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
    Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
    Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone replacement therapy use decreases oxidative protein damage.
    Telci A; Cakatay U; Akhan SE; Bilgin ME; Turfanda A; Sivas A
    Gynecol Obstet Invest; 2002; 54(2):88-93. PubMed ID: 12566750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.
    Lundström E; Wilczek B; von Palffy Z; Söderqvist G; von Schoultz B
    Climacteric; 2001 Mar; 4(1):42-8. PubMed ID: 11379377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
    Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
    Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer.
    Alvarez-Vasquez RB; Axelrod D; Frenkel K; Newman MC; Sepkovic DW; Bradlow HL; Zumoff B
    Horm Metab Res; 2003 Jun; 35(6):358-61. PubMed ID: 12920658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopausal women.
    Cengiz B; Atabekoglu C; Cetinkaya E; Cengiz SD
    Maturitas; 2003 Dec; 46(4):301-6. PubMed ID: 14625127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of continuous administration of conjugated estrogen plus medroxyprogesterone acetate (Premelle) in postmenopausal women in Taiwan.
    Yang TS; Wang HL; Chen YJ; Chang SP; Yuan CC
    J Chin Med Assoc; 2004 Jul; 67(7):336-43. PubMed ID: 15510930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.
    Yilmazer M; Fenkci V; Fenkci S; Sonmezer M; Aktepe O; Altindis M; Kurtay G
    Maturitas; 2003 Dec; 46(4):245-53. PubMed ID: 14625121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of continuous combined hormone replacement therapy on inflammation in hypertensive and/or overweight postmenopausal women.
    Koh KK; Ahn JY; Jin DK; Yoon BK; Kim HS; Kim DS; Shin MS; Son JW; Choi IS; Shin EK
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1459-64. PubMed ID: 12231566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
    Sbarouni E; Kyriakides ZS; Kremastinos DTh
    J Am Coll Cardiol; 1998 Nov; 32(5):1244-50. PubMed ID: 9809932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of different hormone therapies on breast pain in recently postmenopausal women: findings from the Mayo Clinic KEEPS breast pain ancillary study.
    Files JA; Miller VM; Cha SS; Pruthi S
    J Womens Health (Larchmt); 2014 Oct; 23(10):801-5. PubMed ID: 25268853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
    Mc Manus J; Mc Eneny J; Thompson W; Young IS
    Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.
    Orr-Walker BJ; Evans MC; Clearwater JM; Horne A; Grey AB; Reid IR
    Arch Intern Med; 2000 Jul; 160(14):2161-6. PubMed ID: 10904459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.